Therapeutic Effect of Yiqi Tongnao Decoction on Acute Cerebral Infarction of Qi Deficiency and Blood Stasis Type
Jian Guo, Deqi Ren, Xuehui Chang
Abstract
Jian Guo, Deqi Ren, Xuehui Chang
Abstract
The object is to explore the clinical effect of applying Yiqi Tongnao Decoction in the treatment of patients with acute cerebral infarction of Qi deficiency and blood stasis. In this study, patients in our hospital were taken as the main research objects, all of whom were patients with acute cerebral infarction of Qi deficiency and blood stasis type. The number of patients is 100. The study period is from January 2020 to January 2021. The 100 patients selected for this study are divided into two groups. One group is given conventional western medicine treatment as the control group, and the other group is given Yiqi Tongnao Decoction treatment as the experimental group, the therapeutic effects of the two groups of patients were compared and analyzed. The scores of various TCM syndromes of the experimental group were lower than those of the control group, and the scores of neurological deficit and blood viscosity after treatment were lower than those of the control group. The effective rate of treatment was 94.00%, which was higher than 78.00% of the control group. The adverse reaction rate of patients in the group was 6.00%, which was lower than that in the control group, and the differences in the data were statistically significant (P<0.05). The application of Yiqi Tongnao Decoction in patients with acute cerebral infarction of Qi deficiency and blood stasis type has significant clinical effects. It can improve the clinical symptoms of patients, reduce the incidence of adverse reactions, and has a positive significance in promoting the recovery of patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The object is to explore the clinical effect of applying Yiqi Tongnao Decoction in the treatment of patients with acute cerebral infarction of Qi deficiency and blood stasis. In this study, patients in our hospital were taken as the main research objects, all of whom were patients with acute cerebral infarction of Qi deficiency and blood stasis type. The number of patients is 100. The study period is from January 2020 to January 2021. The 100 patients selected for this study are divided into two groups. One group is given conventional western medicine treatment as the control group, and the other group is given Yiqi Tongnao Decoction treatment as the experimental group, the therapeutic effects of the two groups of patients were compared and analyzed. The scores of various TCM syndromes of the experimental group were lower than those of the control group, and the scores of neurological deficit and blood viscosity after treatment were lower than those of the control group. The effective rate of treatment was 94.00%, which was higher than 78.00% of the control group. The adverse reaction rate of patients in the group was 6.00%, which was lower than that in the control group, and the differences in the data were statistically significant (P<0.05). The application of Yiqi Tongnao Decoction in patients with acute cerebral infarction of Qi deficiency and blood stasis type has significant clinical effects. It can improve the clinical symptoms of patients, reduce the incidence of adverse reactions, and has a positive significance in promoting the recovery of patients.
Key concepts: Medicine, Decoction, Blood stasis, Therapeutic effect, Internal medicine, Traditional Chinese medicine, Incidence (geometry), Adverse effect